secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001437402-26-000003
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx reports preliminary Q4 2025 IBSRELA sales ~$87M, XPHOZAH ~$28M; cash $265M
--------------------------------------------------------------------------------

- Preliminary unaudited U.S. net product sales: IBSRELA ~$87M Q4, ~$274M FY 2025.
- Preliminary unaudited U.S. net product sales: XPHOZAH ~$28M Q4, ~$104M FY 2025.
- Cash, cash equivalents and short-term investments ~$265M as of Dec 31, 2025, unaudited.
- All figures are preliminary and subject to adjustment upon final audited results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000143740226000003/0001437402-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000143740226000003/ardx-20260108.htm
  HTML page:      https://secwatch.observer/filing/0001437402-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer